Lead optimization of apyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies

被引：34

作者：

Liang, Jun ^{[1
]}

Zhang, Birong ^{[1
]}

Labadie, Sharada ^{[1
]}

Ortwine, Daniel F. ^{[1
]}

Vinogradova, Maia ^{[1
]}

Kiefer, James R. ^{[1
]}

Gehling, Victor S. ^{[2
]}

Harmange, Jean-Christophe ^{[2
]}

Cummings, Richard ^{[2
]}

Lai, Tommy ^{[3
]}

Liao, Jiangpeng ^{[3
]}

Zheng, Xiaoping ^{[3
]}

Liu, Yichin ^{[1
]}

Gustafson, Amy ^{[1
]}

Van der Porten, Erica ^{[1
]}

Mao, Weifeng ^{[3
]}

Liederer, Bianca M. ^{[1
]}

Deshmukh, Gauri ^{[1
]}

Classon, Marie ^{[1
]}

Trojer, Patrick ^{[2
]}

Dragovich, Peter S. ^{[1
]}

Murray, Lesley ^{[1
]}

机构：

[1] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA

[2] Constellat Pharmaceut Inc, 215 First St,Suite 200, Cambridge, MA 02142 USA

[3] WuXi AppTec, 288 Fute Zhong Rd, Shanghai 200131, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 16期

关键词：

Histone demethylase; KDM5; Selective KDM5 inhibitors; Epigenetics; Drug resistance; Lead optimization; CELL PENETRANT INHIBITORS; DEMETHYLASE INHIBITORS; LYSINE DEMETHYLASES; HISTONE; DERIVATIVES; METHYLATION; INHERITANCE; MECHANISMS; FAMILIES;

D O I：

10.1016/j.bmcl.2016.06.078

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Starting with a lead [1,5-a]pyrimidin-7(4H)-one-containing molecule (1), we generated potent, selective and orally bioavailable KDM5 inhibitors. Using structure- and property-based approaches, we designed 48 with improved cell potency (PC9 H3K4Me3 EC50 = 0.34 mu M). Furthermore, 48 maintained suitable physiochemical properties and displayed an excellent pharmacokinetic (PK) profile in mice. When dosed orally in mice at 50 mg/kg twice a day (BID), 48 showed an unbound maximal plasma concentration (C-max) >15-fold over its cell EC50, thereby providing a robust chemical probe for studying KDM5 biological functions in vivo. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：4036 / 4041

页数：6

共 50 条

[11] Activation of KCNQ2/3 Potassium Channels by Novel Pyrazolo[1,5-a]pyrimidin-7(4H)-One Derivatives
Jia, Caixia
Qi, Jinlong
Zhang, Fan
Mi, Yi
Zhang, Xuan
Chen, Xingjuan
Liu, Li
Du, Xiaona
Zhang, Hailin
PHARMACOLOGY, 2011, 87 (5-6) : 297 - 310
[12] Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7 (4H)-one derivatives as potential GABAA-R ligands
Guerrini, Gabriella
Ciciani, Giovanna
Daniele, Simona
Mannelli, Lorenzo Di Cesare
Ghelardini, Carla
Martini, Claudia
Selleri, Silvia
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (06) : 1901 - 1906
[13] Comparison of Methods of Synthesis of 5-Methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one in Supercritical Carbon Dioxide
Baklykov, Artem, V
Rusinov, Gennady L.
Zyryanov, Grigory, V
Kopchuk, Dmitry S.
Charushin, Valery N.
Artem'ev, Grigory A.
Rusinov, Vladimir L.
Khasanov, Albert F.
MODERN SYNTHETIC METHODOLOGIES FOR CREATING DRUGS AND FUNCTIONAL MATERIALS (MOSM2019), 2020, 2280
[14] Synthesis and in vitro anti-epileptic activities of novel [1,2,4]-triazolo[1,5-a]pyrimidin-7(4H)-one derivatives
Ding, Jing
Cao, Feng-De
Geng, Yan-Ru
Tian, Yuan
Li, Peng
Li, Xiu-Fen
Huang, Long-Jiang
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2019, 21 (12) : 1190 - 1204
[15] Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: A Suitable Scaffold for the Development of Noncamptothecin Topoisomerase I (Top1) Inhibitors
Taliani, Sabrina
Pugliesi, Isabella
Barresi, Elisabetta
Salerno, Silvia
Marchand, Christophe
Agama, Keli
Simorini, Francesca
La Motta, Concettina
Marini, Anna Maria
Di Leva, Francesco Saverio
Marinelli, Luciana
Cosconati, Sandro
Novellino, Ettore
Pommier, Yves
Di Santo, Roberto
Da Settimo, Federico
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7458 - 7462
[16] Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators
Qi, Jinlong
Zhang, Fan
Mi, Yi
Fu, Yan
Xu, Wen
Zhang, Diqun
Wu, Yibing
Du, Xiaona
Jia, Qingzhong
Wang, Kewei
Zhang, Hailin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (03) : 934 - 943
[17] Modulation of Kv7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58
Zhang, F.
Mi, Y.
Qi, J. L.
Li, J. W.
Si, M.
Guan, B. C.
Du, X. N.
An, H. L.
Zhang, H. L.
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (04) : 1030 - 1042
[18] Biological activity of three novel complexes with the ligand 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one against Leishmania spp.
Ramirez-Macias, Inmaculada
Marin, Clotilde
Manuel Salas, Juan
Caballero, Ana
Jose Rosales, Maria
Villegas, Noelia
Rodriguez-Dieguez, Antonio
Barea, Elisa
Sanchez-Moreno, Manuel
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 813 - 819
[19] 4,7-Phenanthrolinium perchlorate-5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-water (1/1/2)
Caballero, Ana B.
Quiros, Miguel
Salas, Juan M.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O459 - U3373
[20] Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma
Zajec, Ziva
Dernovsek, Jaka
Distel, Martin
Gobec, Martina
Tomasic, Tihomir
BIOORGANIC CHEMISTRY, 2023, 131

← 1 2 3 4 5 →